tirzepatide patent expiration date us Drug Patents containing Looming GLP-1 drug patent expirations
Description
Supply shortages compound the problem
P., et al., Efficacy and Safety of a Novel Dual GIP and GLP1 Receptor Agonist Tirzepatide in Patients With Type 2 Diabetes (SURPASS1): A DoubleBlind, Randomised, Phase 3 Trial, Lancet 398, no
While effective, tirzepatide may not be recommended for everyone
Tirzepatide (Mounjaro & Zepbound) Weight Loss Injections in Queens, NY Mounjaro and Zepbound are prescription medications that contain tirzepatide, a GLP-1 and GIP receptor medication that may help support appetite control, satiety, and long-term weight management for eligible adults
LDL cholesterol decreased
